Picture of National Instruments logo

NATI — National Instruments News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge Cap

Emerson’s hostility tests aggressive M&A tools

(The author is a Reuters Breakingviews columnist.  The opinions
expressed are his own.)
    By Robert Cyran
       NEW YORK, Jan 17 (Reuters Breakingviews) - Disclosing
its unsolicited $6.9 bln offer for NI ends a quiet eight-month
standoff. Going public forces the issue, but along with the
target’s strategic review also inflates the price. A bid battle
threatens the potential value of a deal and may inform takeover
tactics elsewhere.
    Full view will be published shortly.
    Follow @rob_cyran on Twitter
    CONTEXT NEWS 
    Engineering services provider Emerson Electric said on Jan.
17 that it had offered to buy NI for $7.6 billion, including
debt. The $53 a share entreaty represents a 13% premium to where
NI’s stock closed on Jan. 13, the last day of trading before the
offer was made public.
    Emerson said it had originally offered $48 per share in May
2022 but was rebuffed. Emerson added that NI, which makes
measurement and testing tools, has not “meaningfully engaged”
since its $53 offer in November.
    NI, previously known as National Instruments, on Jan. 13
enacted a takeover defense tactic known as a poison pill. If a
buyer acquires more than 10% of NI’s stock, other shareholders
will have the right to buy an equal amount of shares as they
hold at a 50% discount. The plan expires on Jan. 12, 2024.
    Emerson has purchased 2.3 million shares in NI, or about
1.8% of the amount outstanding.
 (Editing by Jeffrey Goldfarb and Amanda Gomez)
 ((For previous columns by the author, Reuters customers can
click on  CYRAN/ 
SIGN UP FOR BREAKINGVIEWS EMAIL ALERTS https://bit.ly/BVsubscribe
 | robert.cyran@thomsonreuters.com; Reuters Messaging:
robert.cyran.thomsonreuters.com@reuters.net))

Recent news on National Instruments

See all news